Across TCGA pan-cancer cohorts, MGAT4B RNA is linked to patient survival in 28 of 34 cancer types, making it the most broadly survival-associated MGAT4B data layer compared with 5 for mutation status and 3 for mass-spec protein.
The strongest signal is observed in kidney chromophobe (KICH), where higher MGAT4B RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MGAT4B expression acts as an unfavorable survival marker, although some lineages such as COAD and READ show a favorable association.
KICH, LGG, and COAD are the cancer types where MGAT4B RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.